Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02991677 · ClinicalTrials.gov registry record · NA

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

A NA study of Cancer, Breast and Cancer - Ovarian, sponsored by Baltimore VA Medical Center.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02991677 is a NA study of Cancer, Breast and Cancer - Ovarian that is active but no longer recruiting, run by Baltimore VA Medical Center. The registered enrollment target is 60 participants, below the 10,062-participant average among 10 other Cancer, Breast trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02991677, a NA study of Cancer, Breast and Cancer - Ovarian, is active but no longer recruiting, sponsored by Baltimore VA Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.

Interventions

  • OTHER control group
  • BEHAVIORAL aerobic exercise intervention
  • BEHAVIORAL resistive training

Study Locations (1)

Maryland

  • Baltimore VA Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-03-01
Est. Completion 2025-12
Phase NA

Sponsor

Baltimore VA Medical Center

12 total trials

What the Registry Record Tells You About NCT02991677

The ClinicalTrials.gov registry entry for NCT02991677 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,062-participant average among 10 other Cancer, Breast trials with a reported enrollment target (99% lower). The listed sponsor is Baltimore VA Medical Center, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cancer, Breast appearing as the primary indexed condition, and to 3 interventions - of which control group is the first listed.

NCT02991677 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02991677 about?

NCT02991677 is a clinical study titled "Exercise Effect on Chemotherapy-Induced Neuropathic Pain". Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-relat...

What is the current status of trial NCT02991677?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2018-03-01. Estimated completion is 2025-12.

What conditions does trial NCT02991677 study?

This clinical trial studies the following conditions: Cancer, Breast, Cancer - Ovarian, Cancer Colorectal, Cancer, Lung.

What interventions are being tested in trial NCT02991677?

The interventions under investigation include: control group (OTHER), aerobic exercise intervention (BEHAVIORAL), resistive training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02991677?

This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02991677 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer, Breast

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.